Cipla narrows loss in Jan-March, misses forecasts | Reuters

 Cipla narrows loss in Jan-March, misses forecasts
| Reuters

MUMBAI Cipla Ltd, India's fifth-largest drugmaker by sales, reported a smaller quarterly loss for January-March, but missed expectations of a profit for the period.Net loss for the firm's fourth quarter narrowed to 617.9 million rupees ($9.56 million) from a loss of 928.3 million rupees a year earlier.

Analysts on average had expected the firm would report a profit of 3.45 billion rupees.

The quarter includes a one-off non-cash impairment charge of 21.42 billion rupees related to litigation expenses, and the company also took a provision of 560 million rupees related to its unit Cipla Biotech in the quarter, it said in a statement.

($1 = 64.6125 Indian rupees) (Reporting by Zeba Siddiqui in Mumbai; Editing by Edmund Blair)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Your guide to the latest cricket World Cup stories, analysis, reports, opinions, live updates and scores on Follow us on Twitter and Instagram or like our Facebook page for updates throughout the ongoing event in England and Wales.

Updated Date: May 25, 2017 16:44:51 IST